|
|||
|
1
Blümcke I, Luyken C, Urbach H, Schramm J, Wiestler OD.
An isomorphic subtype of long-term epilepsy-associated astrocytomas associated with benign prognosis. Acta Neuropathol (Berl). 2004; 107(5):381-8
2
Blümcke I, Müller S, Buslei R, Riederer BM, Wiestler OD.
Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumors. Acta Neuropathol (Berl). 2004; 108(2):89-96
3
Clusmann H, Kral T, Gleissner U, Sassen R, Urbach H, Blümcke I, Bogucki J, Schramm J.
Analysis of different types of resection for pediatric patients with temporal lobe epilepsy. Neurosurgery. 2004; 54(4):847-60.
4
Clusmann H, Kral T, Fackeldey E, Blümcke I, Helmstaedter C, von Oertzen J, Urbach H, Schramm J.
Lesional mesial temporal lobe epilepsy and limited resections: prognostic factors and outcome. J Neurol Neurosurg Psychiatry. 2004 Nov; 75(11):1589-96.
5
Fassunke J, Blümcke I, Lahl R, Elger CE, Schramm J, Merkelbach-Bruse S, Mathiak M, Wiestler OD, Becker AJ.
Analysis of chromosomal instability in focal cortical dysplasia of Taylor’s balloon cell type. Acta Neuropathol (Berl). 2004 Aug; 108(2):129-34.
6
Fauser S, Becker A, Schulze-Bonhage A, Hildebrandt M, Tuxhorn I, Pannek HW, Lahl R, Schramm J, Blümcke I.
CD34-immunoreactive balloon cells in cortical malformations. Acta Neuropathol (Berl). 2004; 108(4):272-8
7
Hildebrandt M, Blümcke I.
Fokale kortikale Dysplasien des Menschen. Histologische Befunde und Vorschläge zur Klassifikation. Z Epileptol 17:209-214 (2004).
8
Kam R, Chen J, Blümcke I, Normann S, Fassunke J, Elger CE, Schramm J, Wiestler OD, Becker AJ.
The reelin pathway components disabled-1 and p35 in gangliogliomas – a mutation and expression analysis. Neuropathol Appl Neurobiol. 2004 May 14; 30(3):225-32.
9
Luyken C, Blümcke I, Fimmers R, Urbach H, Wiestler OD, Schramm J.
Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer. 2004 Jul 1; 101(1): 146-55.
10
Pohlmann-Eden B, Gass A, Peters CN, Wennberg R, Blümcke I.
Evolution of MRI changes and development of bilateral hippocampal sclerosis during long lasting generalised status epilepticus. J Neurol Neurosurg Psychiatry. 2004 Jun; 75(6):898-900.
11
Schramm J, Luyken C, Urbach H, Fimmers R, Blümcke I.
Evidence for a clinically distinct new subtype of grade II astrocytomas in patients with long-term epilepsy. Neurosurgery. 2004 Aug; 55(2):340-7; discussion 347-8.
12
Stadlbauer A, Moser E, Gruber S, Buslei R, Nimsky C, Fahlbusch R, Ganslandt O.
Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of (1)H-MRSI metabolites in gliomas. Neuroimage . 2004 Oct; 23(2):454-61.
13
Stefan H, Walter J, Kerling F, Blümcke I, Buchfelder M.
[Supratentorial cavernoma and epileptic seizures: predictors in postoperative control?]. Nervenarzt. 2004; 75(8):755-62.
14
Stefan H, Scheler G, Hummel C, Walter J, Romstock J, Buchfelder M, Blumcke I.
Magnetoencephalography (MEG) predicts focal epileptogenicity in cavernomas. J Neurol Neurosurg Psychiatry. 2004 Sep; 75(9):1309-13.
15
Urbach H, Hattingen J, Von Oertzen J, Luyken C, Clusmann H, Kral T, Kurthen M, Schramm J, Blümcke I, Schild HH.
MR Imaging in the Presurgical Workup of Patients with Drug-Resistant Epilepsy. AJNR Am J Neuroradiol. 2004 Jun; 25(6):919-926.
16
Compiled by Heinz-Gregor Wieser for the ILAE Commission on Neurosurgery of Epilepsy.
Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis. Epilepsia. 2004 Jun; 45(6):695-714.
